Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes

NCT05205005 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

24

Enrollment

FED

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Endocalyx
DRUG: Placebo

Sponsor

VA Office of Research and Development